Cott Corp. (COT) Misses Q1 EPS by 6c, Miss on Revenues
Get Alerts COT Hot Sheet
Price: $14.62 --0%
Financial Fact:
Interest expense, net: 34.4M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense, net: 34.4M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cott Corp. (NYSE: COT) reported Q1 EPS of ($0.13), $0.06 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $896 million versus the consensus estimate of $909.78 million.
FIRST QUARTER 2017 HIGHLIGHTS
- Cott revenue increased 28% to $896 million compared to $698 million.
- Gross profit increased 45% to $311 million compared to $214 million and gross margin as a percentage of revenue increased to 34.6% compared to 30.6%.
- Net cash used in operating activities of $5 million less $41 million of capital expenditures resulted in reported free cash flow usage of ($46) million and adjusted free cash flow usage of ($40) million (adjusted for acquisition, integration, and other cash costs) compared to adjusted free cash flow usage of ($47) million in the prior year representing a $7 million or 15% improvement.
- Issued $750 million of Senior Notes at a rate of 5.5% and an 8 year maturity with the proceeds to be utilized to redeem all $625 million of our 6.75% Senior Notes and $100 million of our 10% Senior Notes.
- Cott continues to target full year 2017 cash flow provided by operations of approximately $330 to $340 million and capital expenditures in the range of $165 to $175 million, resulting in adjusted free cash flow of $155 to $175 million (when excluding acquisition, integration, and other cash costs).
- Cott continues to target full year 2017 revenues of over $3.7 billion.
For earnings history and earnings-related data on Cott Corp. (COT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share